NeuroHawk™
The NeuroHawk™ Thrombectomy Device is an advanced solution designed for efficient and effective removal of thrombus in patients experiencing acute ischemic stroke. Engineered with state-of-the-art technology, NeuroHawk™ offers superior performance, ease of use, and enhanced patient outcomes.
Versatility
The NeuroHawk™ system is highly versatile, thanks to its Hybrid Cell Design, NeuroHawk™ is suitable for a wide range Clot Compositions. Its design allows for efficient thrombus removal in various vessel sizes and anatomical challenges, making it an adaptable tool for different clinical scenarios.
Radiopacity
Enhanced radiopacity is a standout feature of the NeuroHawk™. Equipped with 3 radiopaque wires, the system ensures excellent visibility under fluoroscopy. This facilitates precise navigation and accurate positioning, crucial for the success of neurointerventional procedures.
Deliverability
The NeuroHawk™ is engineered for exceptional deliverability. Its flexible design allows for smooth navigation through tortuous vascular pathways, minimizing the risk of vessel damage. The catheter’s construction ensures easy maneuverability, making it reliable for reaching challenging thrombus locations.
Retrievability
The NeuroHawk™ system includes a retrieval feature that enhances safety and efficiency. This capability ensures that the catheter can be safely retrieved if repositioning is necessary, providing added security and flexibility during the procedure.
Product Specifications
CAPTURE Trial
The CAPTURE trial, conducted across 21 sites in China, investigated the efficacy of the Neurohawk and Solitaire FR devices for endovascular treatment of acute ischemic stroke caused by large vessel occlusions. The trial demonstrated high rates of successful recanalization, but despite this, many patients experienced poor outcomes or mortality within 90 days. A secondary analysis identified key factors associated with these poor outcomes, including older age, higher initial stroke severity (NIHSS score ≥17), internal carotid artery occlusions, and achieving only partial reperfusion (mTICI score 2b).